Search results for: pediatric rheumatology

New D.C. Office Strengthens ACR Advocacy Efforts

Carina Stanton | December 18, 2019

Three full-time, ACR advocacy staffers are now working in Washington, D.C., to provide a daily presence for national rheumatology lobbying efforts.

Case Report: Rheumatoid Arthritis-Associated Restrictive Pericarditis

Scott Rodriguez, MD, Kenton Powell, MD, & Daniel Albert, MD | November 17, 2019

Rheumatoid arthritis (RA) is a systemic autoimmune disease that affects approximately 1% of the adult population, and involvement of extra-articular tissue occurs in approximately 40% of patients over their lifetimes.1 RA-associated pericardial disease is an uncommon complication, and surgery is the only definitive therapy—according to current literature. In this report, we present the case of…

Ellen M. Gravallese, MD, Begins ACR Presidency

Susan Bernstein | November 7, 2019

As Ellen M. Gravallese, MD, begins the ACR presidency, her goals include workforce expansion, improved access to care and support for members in all areas of practice.

Insight into the Characteristics of Orphan Autoinflammatory Disorders

Carina Stanton | November 4, 2019

New research seeking to describe the characteristics of undefined, systemic autoinflammatory diseases may have identified distinct subgroups, including pericarditis and intellectual impairment…

Why You Should Consider Adding a Dietitian to Your Team

Linda Childers | October 18, 2019

A patient with rheumatoid arthritis (RA) asks if diet can help ease their symptoms. Or maybe a patient with severe knee osteoarthritis (OA) seeks diet advice because they want to lose weight and relieve pressure on their joints. Although there’s no specific nutrition plan for patients with rheumatic diseases, research has shown many dietary factors…

Case Report: A Patient on Apremilast Develops Streptococcus Salivarius

Stephanie Kydd Dondero, DO, & Barry Waters, MD | October 18, 2019

Apremilast was first marketed in March 2014 for the treatment of adults with psoriatic arthritis (PsA). An immunomodulating drug, which is a small molecule inhibitor of phosphodiesterase 4 (PDE4) specific for cyclic adenosine monophosphate (cAMP), apremilast is administered orally. By inhibiting PDE4, intracellular cAMP levels are increased. Although the exact mechanism of action is not…

Annual Meeting Preview: Effective Advocacy By & For ACR/ARP Members

Mary Beth Nierengarten | October 3, 2019

Session attendees will hear about recent successes from the Government Affairs Committee and learn how to become effective rheumatology advocates.

Tips for Diagnosing Metabolic Myopathies

Ruth Jessen Hickman, MD | September 17, 2019

When evaluating patients with possible myopathic symptoms, rheumatologists must consider a rare, but important, group of inherited disorders: the metabolic myopathies. However, their diagnosis often remains a challenge. Early recognition of these primary metabolic myopathies is essential to help prevent disease morbidity and mortality from rhabdomyolysis. Here, we focus on the metabolic myopathies that present…

Measles Is Back. How Does This Affect Patients with Rheumatic Disease?

Ruth Jessen Hickman, MD | August 16, 2019

Despite the presence of a highly effective vaccine, measles (rubeola) is still an important problem worldwide, one that has reemerged in some areas of the world where it had previously been almost eradicated. Rheumatology patients may have questions about whether they are sufficiently protected. Here we discuss key considerations for rheumatologists in light of recent…

Healthcare Professionals Can Tap the ARP for Assistance

From the College | August 1, 2019

The ARP has a lot to offer members, including training and professional development, patient resources and volunteer match opportunities.